Skip to main content Skip to section navigation Skip to footer
  • Medical Professionals
    • Information for Healthcare Providers
    • Clinical Studies
    • Expanded Access
    • Educational Grants
    • Request Information
  • Press Releases
  • Suppliers

Atara Biotherapeutics

  • Our Company
    • About Us
    • Responsibility
  • Technology
    • Technology
    • Manufacturing
    • CAR T
  • Pipeline
    • Atara Pipeline
    • Tab-cel®
    • ATA3219
    • ATA3431
  • Patients & Families
    • Our Mission
    • ATA3219 Trial (NHL)
    • ATA3219 Trial (SLE/LN)
    • Stories of Strength
    • About EBV
    • PTLD
    • Clinical Studies
    • Expanded Access
  • Investors & Media
    • Investors & Media
    • News & Events
    • Financial Results
    • ATRA Stock
    • Analyst Coverage
    • SEC Filings
    • Governance
  • Careers
    • Careers Home
    • Career Areas
    • Job Search
  • Contact
  • Medical Professionals
  • Press Releases
  • Suppliers
  • LinkedIn
  • Twitter
  • News
  • Careers
Investors & Media

Investors & Media

  • Investors & Media
  • News & Events
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Email Alerts
    • Investor & Media Contacts
  • Financial Results
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • ATRA Stock
    • Overview
    • Charts
    • Historical Data
    • FAQ
    • Classification Info
  • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board

Investor Relations

News & Events

Events

  • News & Events

  • Overview
  • Press Releases
  • Events
  • Presentations
  • Email Alerts
  • Investor & Media Contacts

Third Quarter 2020 Financial Results Conference Call

Nov 9, 2020 4:30 pm EST
Earnings Release
HTML PDF
10-Q Filing
HTML PDF
XBRL
ZIP
  • Email Alerts
  • Contacts
  • RSS News Feed
Atara Biotherapeutics
  • Home
  • Site Map
  • Terms of Use
  • Privacy Policy
  • Medical Professionals
  • Press Releases
  • Suppliers
LinkedIn Icon Twitter Icon
  • Our Company
  • Technology
  • Pipeline
  • Investors and Media
  • Patients and Families
  • Careers
  • Contact
  • Our Company
  • About Us
  • Responsibility
  • Technology
  • Technology
  • Manufacturing
  • CAR T
  • Investors and Media
  • Investors & Media
  • News & Events
  • Financial Results
  • ATRA Stock
  • Analyst Coverage
  • SEC Filings
  • Governance
  • Pipeline
  • Atara Pipeline
  • Tab-cel®
  • ATA3219
  • ATA3431
  • Careers
  • Careers Home
  • Career Areas
  • Job Search
  • Contact
  • Patients and Families
  • Our Mission
  • Stories of Strength
  • About EBV
  • PTLD
  • Clinical Studies
  • Expanded Access
© 2024 Atara Biotherapeutics, Inc. All rights reserved. Notice of Data Breach